Your browser doesn't support javascript.
loading
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents.
Park, So-Young; Fowler, Stephen; Shaw, Dominic E; Adcock, Ian M; Sousa, Ana R; Djukanovic, Ratko; Dahlen, Sven-Erik; Sterk, Peter J; Kermani, Nazanin Zounemat; Calhoun, William; Israel, Elliot; Castro, Mario; Mauger, Dave; Meyers, Deborah; Bleecker, Eugene; Moore, Wendy; Busse, William; Jarjour, Nizar; Denlinger, Loren; Levy, Bruce; Choi, Byoung-Hwui; Kim, Sae-Hoon; Jang, An-Soo; Lee, Taehoon; Cho, Young-Joo; Shin, Yoo Seob; Cho, Sang-Heon; Won, Sungho; Cruz, Alvaro A; Wenzel, Sally E; Chung, Kian Fan; Kim, Tae-Bum.
Afiliación
  • Park SY; Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Fowler S; Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
  • Shaw DE; Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, University of Manchester and University Hospital of South Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Adcock IM; Respiratory Research Unit, University of Nottingham, Nottingham, UK.
  • Sousa AR; National Heart and Lung Institute, Imperial College London, and Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UK.
  • Djukanovic R; Respiratory Therapeutic Unit, GlaxoSmithKlene, Stockley Park, UK.
  • Dahlen SE; NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, Southampton, UK.
  • Sterk PJ; Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
  • Kermani NZ; Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.
  • Calhoun W; National Heart and Lung Institute, Imperial College London, and Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UK.
  • Israel E; Divisions of Pulmonary, Critical Care, and Sleep Medicine, and Allergy/Immunology; and Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA.
  • Castro M; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Mauger D; Department of Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Meyers D; Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, USA.
  • Bleecker E; University of Arizona Arizona Health Sciences Center, Tucson, AZ, USA.
  • Moore W; University of Arizona Arizona Health Sciences Center, Tucson, AZ, USA.
  • Busse W; Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Jarjour N; UW Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Denlinger L; UW Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Levy B; UW Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Choi BH; Department of Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Kim SH; Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
  • Jang AS; Department of Internal Medicine, Division of Allergy and Clinical Immunology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Lee T; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Korea.
  • Cho YJ; Department of Internal Medicine, Ulsan University Hospital, Ulsan University School of Medicine, Ulsan, Korea.
  • Shin YS; Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
  • Cho SH; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
  • Won S; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Cruz AA; Department of Public Health Science, Seoul National University, Seoul, Korea.
  • Wenzel SE; ProAR Foundation and Federal University of Bahia, Salvador, Brazil. cruz.proar@gmail.com.
  • Chung KF; Department of Environmental Medicine and Occupational Health, Graduate School of Public Health, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. swenzel@pitt.edu.
  • Kim TB; National Heart and Lung Institute, Imperial College London, and Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UK. f.chung@imperial.ac.uk.
Allergy Asthma Immunol Res ; 16(4): 338-352, 2024 Jul.
Article en En | MEDLINE | ID: mdl-39155735
ABSTRACT

PURPOSE:

Asthma is a clinical syndrome with various underlying pathomechanisms and clinical phenotypes. Genetic, ethnic, and geographic factors may influence the differences in clinical presentation, severity, and prognosis. We compared the characteristics of asthma based on the geographical background by analyzing representative cohorts from the United States, Europe, South America, and Asia using the Severe Asthma Research Program (SARP), Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED), Program for Control of Asthma in Bahia (ProAR), and Cohort for Reality and Evolution of Adult Asthma in Korea (COREA), respectively.

METHODS:

The clinical characteristics and medications for the SARP (n = 669), U-BIOPRED (n = 509), ProAR (n = 996), and COREA (n = 3,748) were analyzed. Subgroup analysis was performed for severe asthma.

RESULTS:

The mean age was highest and lowest in the COREA and SARP, respectively. The asthma onset age was lowest in the ProAR. The mean body mass index was highest and lowest in the SARP and COREA, respectively. Baseline pulmonary function was lowest and highest in the U-BIOPRED and COREA, respectively. The number of patients with acute exacerbation in the previous year was highest in U-BIOPRED. The mean blood eosinophil count was highest in COREA. The total immunoglobulin E was highest in the ProAR. The frequency of atopy was highest in the SARP. The principal component analysis plot revealed differences among all cohorts.

CONCLUSIONS:

The cohorts from 4 different continents exhibited different clinical and physiological characteristics, probably resulting from the interplay between genetic susceptibility and geographical factors.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Allergy Asthma Immunol Res Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Allergy Asthma Immunol Res Año: 2024 Tipo del documento: Article